Given that females are less susceptible to SARS-CoV-2 infection and symptoms, despite having higher gene dosing of ACE242, it may be the case that low ACE2, or indeed a ratio shifted towards dACE2, is harmful in COVID-19 outcome, particularly relating to cardiovascular pathology. This evidence concerns the gene ACE2 and COVID-19.